Elevated thymidine kinase 1 in serum following neoadjuvant chemotherapy predicts poor outcome for patients with locally advanced breast cancer

By              

Experimental and Therapeutic Medicine, Vol. 3, Iss. 2, 2012-01 ,pp. : 331-335

Spandidos Publications

Access to resources Recommend Favorite

Elevated chemokine receptor CXCR4 expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for patients with locally advanced breast cancer (LABC)

By Holm Neal   Abreo Fleurette   Johnson Lester   Li Benjamin   Chu Quyen  

Breast Cancer Research and Treatment, Vol. 113, Iss. 2, 2009-01 ,pp. : 293-299

Springer Publishing Company

Access to resources Recommend Favorite

Serious neutropenia following neoadjuvant chemotherapy for locally advanced breast cancer: A case report

By        

Oncology Letters, Vol. 11, Iss. 2, 2016-01 ,pp. : 1597-1599

Spandidos Publications

Access to resources Recommend Favorite

Correlation between response to neoadjuvant chemotherapy and survival in locally advanced breast cancer patients

By Romero A.   Garca-Senz J. A.   Fuentes-Ferrer M.   Lpez Garcia-Asenjo J. A.   Furi V.   Romn J. M.   Moreno A.   de la Hoya M.   Daz-Rubio E.   Martn M.   Calds T.  

Annals of Oncology, Vol. 24, Iss. 3, 2013-03 ,pp. : 655-661

Oxford University Press

Access to resources Recommend Favorite

Docetaxel and high-dose epirubicin as neoadjuvant chemotherapy in locally advanced breast cancer

By Espinosa E.   Morales S.   Borrega P.   Casas A.   Madroñal C.   Machengs I.   Illarramendi J.   Lizón J.   Moreno J.   Belón J.   Janáriz J.   Puente M.   Checa T.   Mel J.   González Barón M.  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 6, 2004-12 ,pp. : 546-552

Springer Publishing Company

Access to resources Recommend Favorite